The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

[227 Pages Report] The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.

Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=2531061

The study involved four major activities in estimating the current size of the transplant diagnostics market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the total market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Based on product, the reagents & consumables segment held the largest share of the market in 2019.
On the basis of product, the transplant diagnostics market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of the global transplant diagnostics market in 2019. Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation and the growing adoption of transplant diagnostic techniques in related research studies are driving the growth of this segment.

Browse and in-depth TOC on “Transplant Diagnostics Market” @ https://www.marketsandmarkets.com/PressReleases/global-transplant-diagnostics.asp

60 – Figures
203 – Pages

Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period.
On the basis of technology, the transplant diagnostics market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period. Factors such as its varied applications in patient profiling, rising public-private investments to support product development, and increasing clinical evidence of its efficacy are driving the growth of this segment.

Based on the transplant type, the solid organ transplantation segment accounted for the largest share of this market in 2019.
On the basis of transplant type, the transplant diagnostics market is categorized into solid organ, stem cell, and soft tissue transplantation. Solid organ transplantation accounted for the largest share of the transplant diagnostics market in 2019. Supportive government regulations to increase organ donations across major healthcare markets, the rising number of chronic diseases/disorders leading to transplantation, and ongoing technological advancements in the field of transplant diagnostics are the key factors supporting the growth of the market for solid organ transplantation.

North America accounted for the largest share of the transplant diagnostics market in 2019
North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers & their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases.

Make an Enquire to Buy this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=2531061

Recent Developments (2016-2019):

• In August 2019, Care Dx (US) acquired XynManagement (US) to simplify transplant quality tracking and waitlist management.

• In March 2019, Hologic established a learning and experience center in Zaventem (Belgium) to create awareness among customers, healthcare professionals, and employees across Europe, the Middle East, and Africa about the benefits of diagnostic products, including transplant diagnostic products.

• In February 2019, Care Dx (US) launched the Allosure for lung transplants.

• In January 2018, F. Hoffman-LA Roche Limited (Switzerland) launched the Cobas Plasma Separation Card.

Key Questions Addressed by the Report:

• What are the growth opportunities related to the adoption of transplant diagnostic products across significant regions in the future?

• Emerging countries show immense opportunities for the growth and adoption of transplant diagnostic instruments, related reagents & consumables, and software. Will this scenario continue in the next five years?

• Where will the advancements in products offered by various companies take the industry in the mid- to long-term?

• What are the newest trends and advancements in the transplant diagnostics market?

About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain-points around revenues decisions.